Form 4: H.B. Fuller CEO Reports Equity Grants and Holdings

H.B. Fuller President and CEO Celeste Beeks Mastin disclosed new performance stock unit grants and updated beneficial ownership of company shares and derivative securities.

Summary

• Celeste Beeks Mastin, President and CEO, and a Director of H.B. Fuller Co. (FUL), reported her beneficial ownership and recent equity transactions.
• The filing indicates a transaction made pursuant to a Rule 10b5-1(c) plan.
• Mastin directly owns 16,119 shares of Common Stock and indirectly owns 3,500 shares through a revocable trust.
• On January 20, 2026, 9,533 Performance Stock Units (PSUs) were acquired, converting to common stock on a 1-for-1 basis upon vesting on January 24, 2026.
• These PSUs reflect H.B. Fuller achieving 80% of the target return on invested capital payout.
• The filing also details existing Employee Stock Options with exercise prices ranging from $64.28 to $77.72, covering a total of 336,291 shares.
• Additionally, Restricted Stock Units (RSUs) totaling 40,138.08 shares are reported, which include amounts from a dividend equivalent reinvestment feature.

Sentiment

Score: 6

Explanation: The sentiment is moderately positive due to the grant of performance-based equity, indicating the company met performance targets (80% of ROIC target). This suggests a degree of operational success, though the filing is primarily a factual disclosure of compensation.

Positives

• The grant of 9,533 Performance Stock Units (PSUs) indicates that H.B. Fuller achieved 80% of its target return on invested capital payout, suggesting positive operational performance.
• The acquisition of PSUs and RSUs aligns management's interests with shareholder value creation through equity incentives.

Risks

• The value of the reported stock options and restricted stock units is subject to the future performance of H.B. Fuller's common stock.
• Performance Stock Units are contingent rights and their ultimate value depends on the company meeting specific performance targets, which were met at 80% of target for the reported grant.

Future Outlook

The filing primarily reports past and scheduled equity compensation events and does not contain explicit forward-looking statements or guidance regarding the company's financial performance or strategic direction.

Industry Context

This Form 4 filing is a routine disclosure of insider equity transactions and holdings, common across all publicly traded companies. It reflects standard executive compensation practices involving performance-based and time-based equity awards, which are prevalent in the manufacturing and specialty chemicals industry to incentivize long-term performance and align executive interests with shareholders.

Comparison to Industry Standards

• The use of Performance Stock Units (PSUs), Restricted Stock Units (RSUs), and Employee Stock Options as part of executive compensation is a standard practice across various industries, including specialty chemicals, aligning with typical global benchmarks for executive incentive plans.
• The vesting schedules (e.g., three annual installments) for options and RSUs are common in corporate compensation structures, comparable to practices at peer companies in the industrial materials sector.

Related Party Transactions

• The filing details equity compensation granted to Celeste Beeks Mastin, President and CEO, which constitutes a transaction between the company and a related party (an executive officer and director).

Stakeholder Impact

• Shareholders: The equity grants align the interests of the CEO with shareholders, as the value of her compensation is tied to the company's stock performance and achievement of financial targets.
• Employees: The compensation structure for the CEO may reflect broader compensation philosophies within the company, potentially influencing employee morale and retention strategies.

Next Steps

• The reported Performance Stock Units are scheduled to vest on January 24, 2026.
• Various Employee Stock Options and Restricted Stock Units have future vesting and expiration dates as detailed in the filing.

Key Dates

Recommendation

This Form 4 filing is a routine disclosure of executive equity compensation and holdings, including grants of performance stock units and restricted stock units, and existing stock options. While the performance stock unit grant indicates the company met 80% of its return on invested capital target, this is a backward-looking performance metric for compensation purposes and does not provide new material information about future operational or financial performance. The transaction was pre-planned under a 10b5-1 plan. As such, it does not present a basis for a change in investment recommendation, and a 'hold' stance is appropriate given the lack of new price-sensitive information.

Keywords

H.B. Fuller, FUL, Form 4, Insider Trading, Beneficial Ownership, Performance Stock Units, Restricted Stock Units, Stock Options, Equity Compensation, CEO, Director, Rule 10b5-1